Zhenshan Zhang

720 Cailun Road
Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Multi-omics biomarkers for predicting resistance, hyperprogression, and immune-related toxicity during PD-1/PD-L1 therapy in lung cancer: a literature review.

Multi-omics biomarkers for predicting resistance, hyperprogression, and immune-related toxicity during PD-1/PD-L1 therapy in lung cancer: a literature review.

Journal: Frontiers in immunology

Published: January 07, 2026

Ubiquitin-centered post-translational modification crosstalk orchestrates tumor immunity and immunotherapy response.

Ubiquitin-centered post-translational modification crosstalk orchestrates tumor immunity and immunotherapy response.

Journal: Experimental hematology & oncology

Published: November 20, 2025

Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune Resistance.

Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune Resistance.

Journal: Cancer medicine

Published: June 27, 2025

Integration of Circulating Tumor DNA and Metabolic Parameters on 18F-Fludeoxyglucose Positron Emission Tomography for Outcome Prediction in Unresectable Locally Advanced Non-Small Cell Lung Cancer.

Integration of Circulating Tumor DNA and Metabolic Parameters on 18F-Fludeoxyglucose Positron Emission Tomography for Outcome Prediction in Unresectable Locally Advanced Non-Small Cell Lung Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 17, 2024

Neutrophils' dual role in cancer: from tumor progression to immunotherapeutic potential.

Neutrophils' dual role in cancer: from tumor progression to immunotherapeutic potential.

Journal: International immunopharmacology

Published: February 01, 2024

Ubiquitin ligase subunit FBXO9 inhibits V-ATPase assembly and impedes lung cancer metastasis.

Ubiquitin ligase subunit FBXO9 inhibits V-ATPase assembly and impedes lung cancer metastasis.

Journal: Experimental hematology & oncology

Published: November 26, 2023

HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma.

HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma.

Journal: Aging

Published: September 28, 2023

The metabolic repression effect of carbon-ion radiotherapy in synchronous hormone-sensitive oligometastatic prostate cancer.

The metabolic repression effect of carbon-ion radiotherapy in synchronous hormone-sensitive oligometastatic prostate cancer.

Journal: Frontiers in endocrinology

Published: September 09, 2023

Carbon ion irradiation exerts antitumor activity by inducing cGAS-STING activation and immune response in prostate cancer-bearing mice.

Carbon ion irradiation exerts antitumor activity by inducing cGAS-STING activation and immune response in prostate cancer-bearing mice.

Journal: Cancer medicine

Published: August 11, 2023

Biological and clinical significance of radiomics features obtained from magnetic resonance imaging preceding pre-carbon ion radiotherapy in prostate cancer based on radiometabolomics.

Biological and clinical significance of radiomics features obtained from magnetic resonance imaging preceding pre-carbon ion radiotherapy in prostate cancer based on radiometabolomics.

Journal: Frontiers in endocrinology

Published: August 04, 2023

Identification and validation of a fatty acid metabolism gene signature for the promotion of metastasis in liver cancer.

Identification and validation of a fatty acid metabolism gene signature for the promotion of metastasis in liver cancer.

Journal: Oncology letters

Published: June 20, 2023

Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non-small cell lung cancer: a multi-institutional retrospective cohort study.

Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non-small cell lung cancer: a multi-institutional retrospective cohort study.

Journal: MedComm

Published: May 28, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026